Hodgkin's and Castleman's disease in a patient with systemic mastocytosis

被引：27

作者：

Saletti, P

Ghielmini, M ^{[1
]}

Scali, G

Pedrinis, E

Guéneau, M

Cavalli, F

机构：

[1] Osped San Giovanni Bellinzona, Dept Oncol, CH-6500 Bellinzona, Switzerland

[2] Swiss Red Cross, Blood Transfus Serv, Div Hematol, Lugano, Switzerland

[3] Inst Pathol, Locarno, Switzerland

[4] Osped Italiano, Dept Internal Med, Viganello, Switzerland

来源：

ANNALS OF HEMATOLOGY | 1999年 / 78卷 / 02期

关键词：

systemic mastocytosis; Hodgkin's disease; Castleman's disease; chemotherapy;

D O I：

10.1007/s002770050482

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Systemic mastocytosis is a rare condition characterized clinically by the local consequences of vasoactive peptides released from infiltrating mast cells in the reticuloendothelial tissues. Mast cells originate from the pluripotent bone marrow stem cells; it is therefore not surprising that myeloproliferative and myelodysplastic disorders commonly coexist or terminate the clinical phase of mastocytosis. We report here, to our knowledge, the first case of Hodgkin's and Castleman's disease occurring in a patient with co-existent systemic mastocytosis, which remained unchanged after combination chemotherapy for Hodgkin's disease.

引用

页码：97 / 100

页数：4

共 26 条

[1]

AbdelReheim FA, 1996, ARCH PATHOL LAB MED, V120, P91

[2] HEMATOLOGIC MALIGNANCIES OCCURRING IN PATIENTS WITH URTICARIA PIGMENTOSA [J].